Sulindac (Standard)
Sulindac (Standard) is the analytical standard of Sulindac. This product is intended for research and analytical applications. Sulindac (MK-231) is an orally active nonsteroidal anti-inflammatory agent. Sulindac also is an immunomodulatory agent. Sulindac can be used for the research of arthritis of the spine, gouty arthritis and kinds of cancer including colorectal cancer (CRC) and lung cancer.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 純度 : 98%
- CAS 番号: 38194-50-2
- 分子式: C20H17FO3S
- 分子量:356.41
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Product Information
-
化学情報
- 純度とドキュメンテーション
-
Help & FAQs
-
HY-B0008
SulindacAnti-inflammatory Agent -
HY-15030
NaproxenCOX Inhibitor -
HY-15030R
Naproxen (Standard)COX Inhibitor -
HY-14398
CelecoxibCOX-2inhibitor -
HY-B0261
MeloxicamCOX Inhibitor -
HY-78131
IbuprofenCOX-1 Inhibitor -
HY-15762
ValdecoxibCOX-2 Inhibitor -
HY-17372
Rofecoxib -
HY-14398R
Celecoxib (Standard)COX-2inhibitor -
HY-78131R
Ibuprofen (Standard)COX-1 Inhibitor -
HY-B0363
NimesulideCOX Inhibitor -
HY-B0261R
Meloxicam (Standard)COX Inhibitor
Product Information
説明
アプリケーション
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
化学情報
-
CAS 番号 38194-50-2
-
分子量 356.41
-
分子式 C20H17FO3S
-
SMILES
O=C(CC(C1=C2C=CC(F)=C1)=C(/C2=C/C3=CC=C(C=C3)S(C)=O)C)O
-
別名
MK-231 (Standard)
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
[1]. Byong-Ki Cha, et al. Celecoxib and sulindac inhibit TGF-β1-induced epithelial-mesenchymal transition and suppress lung cancer migration and invasion via downregulation of sirtuin 1. Oncotarget. 2016 Aug 30;7(35):57213-57227. [Content Brief]
[2]. Bin Yi, et al. Sulindac Modulates the Response of Proficient MMR Colorectal Cancer to Anti-PD-L1 Immunotherapy. Mol Cancer Ther. 2021 Jul;20(7):1295-1304. [Content Brief]
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
Sulindac (Standard) 関連分類
HY-B0008R 関連分類
Powered by Bioz